BeStock  
Markets › Compare › BF.A vs HALO

BF.A vs HALO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BF.A · Brown-Forman-A$26.79 ▲ 0.45%
HALO · Halozyme Therapeutics$108.31 ▼ 1.41%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

80105130155180Oct 7, '25Apr 7, '26Oct 5, '26
  • BF.A +0.6%
  • HALO +64.1%

Head to head

MetricBF.AHALO
Price$26.79$108.31
Change today▲ 0.45%▼ 1.41%
Market cap$12.29B$12.29B
Return, 3 months+1.9%+32.8%
Return, year to date+4.5%+60.9%
Return, 1 year+1.3%+61.7%
P/E (TTM)17.331.8
P/B3.185.6
P/E percentile vs own 5y–92nd
Dividend yield3.43%–
Revenue growth (YoY, latest qtr)–+47.7%
Net profit growth (YoY)–+39.2%
Gross margin–82.4%
Operating margin–55.9%
Net margin–24.9%
Return on equity–173.7%
Analyst target vs. price–-4.1%
Analyst buy share–83%
RSI (14)4850
30-day volatility22.8%26.3%
Max drawdown, 1 year-24.2%-24.1%
Trend readLeaning bullishLeaning bearish
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BF.A is the largest of the group by market value.
  • HALO has returned the most over the past year.
  • BF.A carries the lowest trailing P/E.
  • BF.A has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top